12/23/24 16:39 | 12/23/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -246 | 19.59 | 0 | -13 | 0 | 3,776 | D | | | | | | | | | | | | | | |
12/20/24 18:04 | 12/18/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -567 | 21.24 | 0 | -27 | -1 | 3,788 | D | | | | | | | | | | | | | | |
2/2/24 17:25 | 1/31/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 836 | 14.54 | 0 | 57 | 2 | 3,715 | D | | | | | | | | | | | | | | |
2/2/24 17:25 | 1/31/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.d | -1,860 | 32.35 | 0 | -57 | -2 | 3,715 | D | | | | | | | | | | | | | | |
1/4/24 17:25 | 1/2/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -309 | 31.01 | 0 | -10 | 0 | 3,715 | D | | | | | | | | | | | | | | |
12/22/23 17:04 | 12/20/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -342 | 28.54 | 0 | -12 | 0 | 3,725 | D | | | | | | | | | | | | | | |
10/27/23 18:23 | 10/25/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -589 | 24.21 | 0 | -24 | -1 | 3,737 | D | | | | | | | | | | | | | | |
9/20/23 18:10 | 9/18/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 274 | 4.75 | 0 | 58 | 2 | 3,761 | D | | | | | | | | | | | | | | |
9/20/23 18:10 | 9/18/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.d | -1,624 | 28.12 | 0 | -58 | -2 | 3,761 | D | | | | | | | | | | | | | | |
5/5/23 19:04 | 5/3/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.dm | 211 | 2.01 | 0 | 105 | 3 | 3,761 | D | | | | | | | | | | | | | | |
5/5/23 19:04 | 5/3/23 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.dm | -4,126 | 39.32 | 0 | -105 | -3 | 3,761 | D | | | | | | | | | | | | | | |
9/29/22 17:15 | 9/27/22 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M | 1,251 | 30.79 | 0 | 41 | 1 | 3,468 | D | | | | | | | | | | | | | | |
7/11/22 20:08 | 7/7/22 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 36 | 14.54 | 0 | 3 | 0 | 4,060 | D | | | | | | | | | | | | | | |
2/14/22 08:54 | 2/11/22 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 760 | 5.19 | 0 | 146 | 4 | 4,058 | D | | | | | | | | | | | | | | |
2/14/22 08:54 | 2/11/22 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.d | -7,599 | 51.91 | 0 | -146 | -3 | 4,058 | D | | | | | | | | | | | | | | |
1/7/22 21:39 | 1/7/22 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 61 | 5.19 | 0 | 12 | 0 | 4,058 | D | | | | | | | | | | | | | | |
12/23/21 21:52 | 12/23/21 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 61 | 5.19 | 0 | 12 | 0 | 3,246 | D | | | | | | | | | | | | | | |
12/17/21 20:14 | 12/15/21 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -4,053 | 67.56 | 0 | -60 | -2 | 3,219 | D | | | | | | | | | | | | | | |
10/22/21 17:58 | 10/20/21 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.m | -4,275 | 65.77 | 0 | -65 | -2 | 3,279 | D | | | | | | | | | | | | | | |
12/22/20 17:55 | 12/18/20 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 232 | 5.73 | 0 | 41 | 2 | 2,546 | D | | | | | | | | | | | | | | |
12/10/20 19:07 | 12/8/20 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.dm | 111 | 2.01 | 0 | 55 | 2 | 2,505 | D | | | | | | | | | | | | | | |
12/10/20 19:07 | 12/8/20 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.dm | -3,780 | 68.73 | 0 | -55 | -2 | 2,505 | D | | | | | | | | | | | | | | |
10/23/20 19:35 | 10/23/20 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -5,821 | 58.21 | 0 | -100 | -4 | 2,505 | D | | | | | | | | | | | | | | |
8/14/20 18:08 | 8/13/20 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 495 | 9.90 | 0 | 50 | 2 | 2,605 | D | | | | | | | | | | | | | | |
8/14/20 18:08 | 8/13/20 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.d | -2,068 | 41.35 | 0 | -50 | -2 | 2,605 | D | | | | | | | | | | | | | | |
6/26/20 18:02 | 6/25/20 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -3,881 | 38.81 | 0 | -100 | -4 | 2,605 | D | | | | | | | | | | | | | | |
12/27/19 16:54 | 12/24/19 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -5,292 | 63.50 | 0 | -83 | -4 | 1,805 | D | | | | | | | | | | | | | | |
12/13/19 18:35 | 12/12/19 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.m | -12,310 | 67.15 | 0 | -183 | -9 | 1,889 | D | | | | | | | | | | | | | | |
12/4/19 18:48 | 12/2/19 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.m | -3,367 | 67.33 | 0 | -50 | -2 | 2,072 | D | | | | | | | | | | | | | | |
10/11/19 19:31 | 10/10/19 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 293 | 5.20 | 0 | 56 | 3 | 2,122 | D | | | | | | | | | | | | | | |
10/11/19 19:31 | 10/10/19 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.d | -1,793 | 31.83 | 0 | -56 | -3 | 2,122 | D | | | | | | | | | | | | | | |
9/27/19 21:16 | 9/25/19 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -565 | 28.25 | 0 | -20 | -1 | 2,122 | D | | | | | | | | | | | | | | |
9/24/19 21:12 | 9/20/19 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.dm | 575 | 5.10 | 0 | 113 | 6 | 2,142 | D | | | | | | | | | | | | | | |
9/24/19 21:12 | 9/20/19 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.dm | -3,215 | 28.54 | 0 | -113 | -5 | 2,142 | D | | | | | | | | | | | | | | |
5/29/19 18:57 | 5/24/19 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | M.d | 105 | 2.13 | 0 | 49 | 2 | 2,142 | D | | | | | | | | | | | | | | |
4/5/19 18:57 | 4/3/19 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -965 | 19.30 | 0 | -50 | -2 | 2,092 | D | | | | | | | | | | | | | | |
12/21/18 17:15 | 12/19/18 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -1,253 | 13.92 | 0 | -90 | -6 | 1,542 | D | | | | | | | | | | | | | | |
12/14/18 17:18 | 12/12/18 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -1,266 | 14.07 | 0 | -90 | -5 | 1,632 | D | | | | | | | | | | | | | | |
11/9/18 19:01 | 11/9/18 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -1,173 | 14.39 | 0 | -82 | -5 | 1,722 | D | | | | | | | | | | | | | | |
9/5/18 16:23 | 8/31/18 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.m | -2,382 | 14.45 | 0 | -165 | -8 | 1,804 | D | | | | | | | | | | | | | | |
3/16/18 18:09 | 3/16/18 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S | -192 | 7.40 | 0 | -26 | -1 | 1,969 | D | | | | | | | | | | | | | | |
3/15/18 18:58 | 3/13/18 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anzalone Christopher Richard | CA | DO | CEO | S.m | -2,228 | 7.43 | 0 | -300 | -13 | 1,995 | D | | | | | | | | | | | | | | |
7/5/16 18:11 | 6/30/16 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Anzalone Christopher Richard | CA | DO | CEO | M.d | 80 | 5.09 | 3 | 16 | 1 | 1,117 | D | -58 | -20 | -11 | 9 | 1 | -6 | -3 | 4 | 2 | 7 | 7 | 36 | -69 | |
10/15/14 18:33 | 10/15/14 | ARWR | Arrowhead Research Corp | DE | Health | Biolab | Commercial Physical & Biologi | Anzalone Christopher Richard | CA | DO | P,CEO | P.a | 101 | 6.32 | 33 | 16 | 7 | 260 | D | 153 | -28 | -49 | -50 | -64 | -63 | -58 | -15 | 8 | 5 | 1 | 4 | 10 | -22 |
10/15/14 17:31 | 10/15/14 | ARWR | Arrowhead Research Corp | DE | Health | Biolab | Commercial Physical & Biologi | Anzalone Christopher Richard | CA | DO | P,CEO | P | 101 | 6.32 | 33 | 16 | 7 | 260 | D | 153 | -28 | -49 | -50 | -64 | -63 | -58 | -15 | 8 | 5 | 1 | 4 | 10 | -22 |
8/31/10 17:58 | 8/31/10 | ARWR | Arrowhead Research Corp | DE | Health | Biolab | Commercial Physical & Biologi | Anzalone Christopher Richard | CA | DO | P,CEO | P | 9 | 0.8900 | 0 | 10 | 3 | 342 | D | -47 | 77 | 67 | -39 | -17 | -16 | -8 | 0 | 6 | 10 | 13 | 4 | -28 | -42 |
8/30/10 16:19 | 8/27/10 | ARWR | Arrowhead Research Corp | DE | Health | Biolab | Commercial Physical & Biologi | Anzalone Christopher Richard | CA | DO | P,CEO | P | 9 | 0.8900 | 0 | 10 | 3 | 332 | D | -50 | 80 | 73 | -35 | -18 | -21 | -9 | -5 | 1 | 15 | 13 | 8 | -25 | -47 |
8/25/08 20:01 | 8/22/08 | ARWR | Arrowhead Research Corp | DE | Health | Biolab | Commercial Physical & Biologi | Anzalone Christopher Richard | CA | DO | P,CEO | P.d | 0 | 0.00 | 0 | 164 | New | 164 | D | -66 | -66 | -30 | -33 | -28 | -21 | -17 | -9 | 8 | 7 | -3 | -7 | -72 | -71 |